Joseph Hedde

Joseph Hedde has worked in the pharmaceutical industry since 1996. Joseph started their career at Pfizer as an Assistant Scientist, then moved to Bayer as a Senior Associate II in 2000. In 2004, they returned to Pfizer PGRD as a Scientist. In 2016, they were promoted to Senior Scientist at Pfizer Inc. Joseph then moved to Biogen in 2018, where they held the roles of Principal Associate Scientist, Scientist I, and Scientist I. In 2020, they joined Triplet Therapeutics as a Sr. Scientist, and in 2022, they became the Research Director at MindImmune Therapeutics, Inc., a pharmaceutical company developing drugs targeting the immune system.

Joseph Hedde attended Penn State University from 1992 to 1996, where they earned a Bachelor of Science in Biology.